Gregory S. Curhan
Equibles does not estimate personal net worth.
Get an email with a short summary when Serina Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get SER alertsAbout Gregory S. Curhan
Gregory S. Curhan is recorded as CFO at Serina Therapeutics, Inc. (SER). The newest filing on record that lists Gregory S. Curhan as CFO at Serina Therapeutics, Inc. (SER) is dated April 27, 2026. Earlier roles on record: CFO at Elicio Therapeutics, Inc. (ELTX) until June 1, 2023. Serina Therapeutics, Inc. reported in an 8-K filed August 16, 2024 that Gregory S. Curhan was appointed Chief Financial Officer, effective August 16, 2024. Elicio Therapeutics, Inc. reported in an 8-K filed June 2, 2023 that Gregory S. Curhan was terminated as Angion's Chief Financial Officer, effective June 1, 2023. The proxy statement of Serina Therapeutics, Inc. reports total compensation of $1,700,413 for Gregory S. Curhan in fiscal 2024. Serina Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Serina Therapeutics, Inc. includes Joanne M. Hackett (CEO), Steve Ledger (CEO), Steven Ledger (CEO and Board Member) and 7 others.
“On August 15, 2024, the Board of Directors (the "Board") of Serina Therapeutics, Inc. (the "Company") appointed Gregory S. Curhan as the Company's Chief Financial Officer in a non-employee consultant role, effective August 16, 2024.”
“each of Gregory S. Curhan, Angion's Chief Financial Officer and Jay R. Venkatesan, M.D., were terminated as employees of the Company effective as of the effective time of the Merger.”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 27, 2026
-
Start not stated–2023-06-01
Company network
Leadership on record at Serina Therapeutics, Inc.
- Joanne M. Hackett CEO
- Steve Ledger CEO
- Steven Ledger CEO, Board Member
- Gregory H. Bailey Chairman, Board Member
- J. Milton Harris Chairman, Board Member
- Lead Investor Chairman
- Simba Gill Chairman
- Simba Gill, Ph.D. Chairman
- Andrea E. Park CFO, Chief Accounting Officer
- Andrea Park CFO, Chief Accounting Officer
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Serina Therapeutics, Inc. (SER) | Chief Financial Officer — | — | $1,700,413 |